ВКЛАД ТИПОЛОГИЙ ЧЕЛОВЕКА В СОСТОЯНИЕ СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ В УСЛОВИЯХ НОРМЫ И ПАТОЛОГИИ
PDF

Як цитувати

Мамажонов, А., Соколенко, А., Ткаченко, Е., & Соколенко, В. (2020). ВКЛАД ТИПОЛОГИЙ ЧЕЛОВЕКА В СОСТОЯНИЕ СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ В УСЛОВИЯХ НОРМЫ И ПАТОЛОГИИ. Матеріали конференцій Молодіжної наукової ліги, 74-78. https://doi.org/10.36074/19.06.2020.v1.03
https://doi.org/10.36074/19.06.2020.v1.03
PDF

Посилання

Juster, R.P., Lupien, S. (2012) A sex- and gender-based analysis of allostatic load and physical complaints. Gend Med. 9(6). 511-523.

Maric-Bilkan, C., Manigrasso, M.B. (2012). Sex differences in hypertension: contribution of the renin-angiotensin system. Gend Med. 9(4).287-291.

Sclavo, M. (2001). Cardiovascular risk factors and prevention in women: similarities and differences. Ital Heart J Suppl. 2(2).125-141. 4. Wehrmacher, W.H. (2012). Women and heart disease: shifting the paradigm in the 21st century. Gend Med. 9(5).385-386.

Marrugat, J., Sala, J., Aboal, J. (2006). Epidemiology of cardiovascular disease in women. Rev Esp Cardiol.59(3).264-274.

Regitz-Zagrosek, V., Seeland, U. (2011). Sex and gender differences in myocardial hypertrophy and heart failure. Wien Med Wochenschr. 161(5-6).109-116.

McSweeney, J., Pettey, C., Lefler, L.L., Heo, S. (2012). Disparities in heart failure and other cardiovascular diseases among women. Womens Health (Lond Engl).8(4).473-485.

Regitz-Zagrosek, V., Lehmkuhl, E. (2005). Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen. Herz. 30(5).356-367.

Regitz-Zagrosek, V., Lehmkuhl, E., Lehmkuhl, H.B.(2008). Heart failure - are there gender aspects. Internist (Berl). 49(4).422-426, 428.

Barnes, J.N. (2013). Blood pressure regulation in women - differences emerge when challenged by orthostasis. J Physiol.1;591(Pt 9).2239.

Wenner, M.M., Haddadin, A.S., Taylor, H.S., Stachenfeld, N.S. (2013). Mechanisms contributing to low orthostatic tolerance in women: the influence of oestradiol. J Physiol.1;591(Pt 9).2345-2355.

Wenner, M.M., Taylor, H.S., Stachenfeld, N.S.(2011). Progesterone enhances adrenergic control of skin blood flow in women with high but not low orthostatic tolerance. J Physiol.15;589(Pt 4).975-986.

Maric-Bilkan, C., Manigrasso, M.B.(2012). Sex differences in hypertension: contribution of the renin-angiotensin system. Gend Med.9(4).287-291.

Raffetto, J.D., Qiao, X., Beauregard, K.G., Khalil, R.A. (2010). Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins. J Vasc Surg. 51(4).972-981.

Wenner, M.M., Stachenfeld, N.S.(2012). Blood pressure and water regulation: understanding sex hormone effects within and between men and women. J Physiol. 1;590(Pt 23).5949-5961.

Mittendorfer, B. Sexual dimorphism in human lipid metabolism. (2005). J Nutr. 135(4).681-686. 17. Wang, X., Magkos, F., Mittendorfer, B. (2011). Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J Clin Endocrinol Metab. 96(4).885-893.

Regitz-Zagrosek, V. (2003). Cardiovascular disease in postmenopausal women. Climacteric. 6 Suppl 3.13-20.

Sitruk-Ware, R. (1995). Cardiovascular risk at the menopause-role of sexual steroids. Horm Res.43(1-3).58-63.

Rosano, G.M., Panina, G. (1999). Oestrogens and the heart. Therapie.54(3).381-385.

Cong, B., Xu, Y., Sheng, H., Zhu, X., Wang, L., Zhao, W., Tang, Z., Lu, J., Ni, X. (2014). Cardioprotection of 17β-estradiol against hypoxia/reoxygenation in cardiomyocytes is partly through up-regulation of CRH receptor type 2. Mol Cell Endocrinol. 25;382(1).17-25.

Cong, B., Zhu, X., Cao, B., Xiao, J., Wang, Z., Ni, X. (2013). Estrogens protect myocardium against ischemia/reperfusion insult by up-regulation of CRH receptor type 2 in female rats. Int J Cardiol. 12;168(5).4755-4760.

Obradovic, M., Bjelogrlic, P., Rizzo, M., Katsiki, N., Haidara, M., Stewart, A.J., Jovanovic, A., Isenovic, E.R. (2013). Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases. J Endocrinol. 29;218(3).R13-23.

Yang, S.G., Mlček, M., Kittnar, O. (2013). Estrogen can modulate menopausal women's heart rate variability. Physiol Res.12;62 Suppl 1. S165-171.

Souza, H.C., Tezini, G.C. (2013). Autonomic Cardiovascular Damage during Post-menopause: the Role of Physical Training. Aging Dis.20;4(6).320-328.

Luisi, S., Orlandini, C., Biliotti, G., Scolaro, V., De Felice, G., Regini, C., Petraglia, F. (2013). Hormone replacement therapy in menopause and in premature ovarian insufficiency. Minerva Ginecol.65(6).607-620.

Masood, D.E., Roach, E.C., Beauregard, K.G., Khalil, R.A. (2010). Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. Curr Drug Metab.11(8).693-714.

Vassalle, C., Simoncini, T., Chedraui, P., Pérez-López, F.R. (2012). Why sex matters: the biological mechanisms of cardiovascular disease. Gynecol Endocrinol. 28(9).746-751.

Khalil, R.A. (2013). Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease. Biochem Pharmacol. 15;86(12).1627-1642.

Austin, E.D., Lahm, T., West, J., Tofovic, S.P., Johansen, A.K., Maclean, M.R., Alzoubi, A., Oka, M. (2013). Gender, sex hormones and pulmonary hypertension. Pulm Circ.3(2).294-314.

Manes, A., Palazzini, M., Dardi, F., D'Adamo, A., Rinaldi, A., Galiè, N. (2012). Female gender and pulmonary arterial hypertension: a complex relationship. G Ital Cardiol (Rome). 13(6).448-460.

Srichaiveth, B., Ruengsakulrach, P., Visudharom, K., Sanguanwong, S., Tangsubutr, W., Insamian, P. (2007). Impact of gender on treatment and clinical outcomes in acute ST elevation myocardial infarction patients in Thailand. J Med Assoc Thai. 90 Suppl 1. 65-73.

Rosano, G.M., Fini, M. (2001). Comparative cardiovascular effects of different progestins in menopause. Int J Fertil Womens Med. 46(5). 248-256.

Howard, B.V., Rossouw, J.E. (2013). Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative. Curr Opin Lipidol. 24(6).493-499.

Rossouw, J.E., Manson, J.E., Kaunitz, A.M., Anderson, G.L. (2013). Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. Obstet Gynecol. 121(1). 172-176.

Manson, J.E., Chlebowski, R.T., Stefanick, M.L., Aragaki, A.K., Rossouw, J.E., Prentice, R.L., Anderson, G., Howard, B.V., Thomson, C.A., LaCroix, A.Z., Wactawski-Wende, J., Jackson, R.D., Limacher, M., Margolis, K.L., Wassertheil-Smoller, S., Beresford, S.A., Cauley, J.A., Eaton, C.B., Gass, M., Hsia, J., Johnson, K.C., Kooperberg, C., Kuller, L.H., Lewis, C.E., Liu, S., Martin, L.W., Ockene, J.K., O'Sullivan, M.J., Powell, L.H., Simon, M.S., Van Horn, L., Vitolins, M.Z., Wallace, R.B. (2013). Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA.2;310(13).1353-1368.

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.

Завантаження

Дані завантаження ще не доступні.

| Переглядів: 15 | Завантажень: 14 |